| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,556 |
10,669 |
$847K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,743 |
5,222 |
$608K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,499 |
8,049 |
$278K |
| 96160 |
|
11,696 |
10,863 |
$215K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,186 |
1,141 |
$166K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
980 |
930 |
$117K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,525 |
2,345 |
$101K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
546 |
508 |
$68K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
446 |
418 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
766 |
683 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,189 |
1,145 |
$27K |
| 96127 |
|
516 |
450 |
$10K |
| 99051 |
|
1,361 |
1,266 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
935 |
863 |
$9K |
| 92552 |
|
653 |
617 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
418 |
376 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
167 |
164 |
$4K |
| 99173 |
|
568 |
540 |
$4K |
| D0145 |
Oral evaluation for a patient under three years of age |
93 |
92 |
$3K |
| 96161 |
|
118 |
118 |
$2K |
| 99174 |
|
134 |
127 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
15 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$2K |
| 90686 |
|
4,591 |
4,332 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
53 |
49 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
14 |
$1K |
| 94010 |
|
57 |
56 |
$952.07 |
| 36416 |
|
294 |
287 |
$908.41 |
| 99188 |
|
39 |
37 |
$771.12 |
| D1206 |
Topical application of fluoride varnish |
12 |
12 |
$297.60 |
| 90656 |
|
466 |
422 |
$245.85 |
| 83655 |
|
14 |
13 |
$150.28 |
| 85018 |
|
262 |
258 |
$6.78 |
| 90670 |
|
206 |
204 |
$0.00 |
| 90633 |
|
30 |
27 |
$0.00 |
| 90734 |
|
15 |
12 |
$0.00 |
| 90744 |
|
14 |
14 |
$0.00 |
| 90698 |
|
161 |
159 |
$0.00 |
| 99000 |
|
136 |
128 |
$0.00 |
| 90680 |
|
30 |
30 |
$0.00 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
165 |
163 |
$0.00 |